Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GPCR-targeting Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Reagent Test Kit
1.2.3 Substrate
1.3 Market by Application
1.3.1 Global GPCR-targeting Drug Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global GPCR-targeting Drug Market Perspective (2018-2033)
2.2 GPCR-targeting Drug Growth Trends by Region
2.2.1 Global GPCR-targeting Drug Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 GPCR-targeting Drug Historic Market Size by Region (2018-2023)
2.2.3 GPCR-targeting Drug Forecasted Market Size by Region (2024-2033)
2.3 GPCR-targeting Drug Market Dynamics
2.3.1 GPCR-targeting Drug Industry Trends
2.3.2 GPCR-targeting Drug Market Drivers
2.3.3 GPCR-targeting Drug Market Challenges
2.3.4 GPCR-targeting Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GPCR-targeting Drug Players by Revenue
3.1.1 Global Top GPCR-targeting Drug Players by Revenue (2018-2023)
3.1.2 Global GPCR-targeting Drug Revenue Market Share by Players (2018-2023)
3.2 Global GPCR-targeting Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by GPCR-targeting Drug Revenue
3.4 Global GPCR-targeting Drug Market Concentration Ratio
3.4.1 Global GPCR-targeting Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GPCR-targeting Drug Revenue in 2022
3.5 GPCR-targeting Drug Key Players Head office and Area Served
3.6 Key Players GPCR-targeting Drug Product Solution and Service
3.7 Date of Enter into GPCR-targeting Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GPCR-targeting Drug Breakdown Data by Type
4.1 Global GPCR-targeting Drug Historic Market Size by Type (2018-2023)
4.2 Global GPCR-targeting Drug Forecasted Market Size by Type (2024-2033)
5 GPCR-targeting Drug Breakdown Data by Application
5.1 Global GPCR-targeting Drug Historic Market Size by Application (2018-2023)
5.2 Global GPCR-targeting Drug Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America GPCR-targeting Drug Market Size (2018-2033)
6.2 North America GPCR-targeting Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America GPCR-targeting Drug Market Size by Country (2018-2023)
6.4 North America GPCR-targeting Drug Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GPCR-targeting Drug Market Size (2018-2033)
7.2 Europe GPCR-targeting Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe GPCR-targeting Drug Market Size by Country (2018-2023)
7.4 Europe GPCR-targeting Drug Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GPCR-targeting Drug Market Size (2018-2033)
8.2 Asia-Pacific GPCR-targeting Drug Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific GPCR-targeting Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific GPCR-targeting Drug Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GPCR-targeting Drug Market Size (2018-2033)
9.2 Latin America GPCR-targeting Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America GPCR-targeting Drug Market Size by Country (2018-2023)
9.4 Latin America GPCR-targeting Drug Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GPCR-targeting Drug Market Size (2018-2033)
10.2 Middle East & Africa GPCR-targeting Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa GPCR-targeting Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa GPCR-targeting Drug Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PerkinElmer
11.1.1 PerkinElmer Company Detail
11.1.2 PerkinElmer Business Overview
11.1.3 PerkinElmer GPCR-targeting Drug Introduction
11.1.4 PerkinElmer Revenue in GPCR-targeting Drug Business (2018-2023)
11.1.5 PerkinElmer Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific GPCR-targeting Drug Introduction
11.2.4 Thermo Fisher Scientific Revenue in GPCR-targeting Drug Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck GPCR-targeting Drug Introduction
11.3.4 Merck Revenue in GPCR-targeting Drug Business (2018-2023)
11.3.5 Merck Recent Development
11.4 BD Biosciences
11.4.1 BD Biosciences Company Detail
11.4.2 BD Biosciences Business Overview
11.4.3 BD Biosciences GPCR-targeting Drug Introduction
11.4.4 BD Biosciences Revenue in GPCR-targeting Drug Business (2018-2023)
11.4.5 BD Biosciences Recent Development
11.5 Molecular Devices
11.5.1 Molecular Devices Company Detail
11.5.2 Molecular Devices Business Overview
11.5.3 Molecular Devices GPCR-targeting Drug Introduction
11.5.4 Molecular Devices Revenue in GPCR-targeting Drug Business (2018-2023)
11.5.5 Molecular Devices Recent Development
11.6 Promega
11.6.1 Promega Company Detail
11.6.2 Promega Business Overview
11.6.3 Promega GPCR-targeting Drug Introduction
11.6.4 Promega Revenue in GPCR-targeting Drug Business (2018-2023)
11.6.5 Promega Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen GPCR-targeting Drug Introduction
11.7.4 Qiagen Revenue in GPCR-targeting Drug Business (2018-2023)
11.7.5 Qiagen Recent Development
11.8 Abcam
11.8.1 Abcam Company Detail
11.8.2 Abcam Business Overview
11.8.3 Abcam GPCR-targeting Drug Introduction
11.8.4 Abcam Revenue in GPCR-targeting Drug Business (2018-2023)
11.8.5 Abcam Recent Development
11.9 Corning
11.9.1 Corning Company Detail
11.9.2 Corning Business Overview
11.9.3 Corning GPCR-targeting Drug Introduction
11.9.4 Corning Revenue in GPCR-targeting Drug Business (2018-2023)
11.9.5 Corning Recent Development
11.10 Discoverx
11.10.1 Discoverx Company Detail
11.10.2 Discoverx Business Overview
11.10.3 Discoverx GPCR-targeting Drug Introduction
11.10.4 Discoverx Revenue in GPCR-targeting Drug Business (2018-2023)
11.10.5 Discoverx Recent Development
11.11 Cisbio
11.11.1 Cisbio Company Detail
11.11.2 Cisbio Business Overview
11.11.3 Cisbio GPCR-targeting Drug Introduction
11.11.4 Cisbio Revenue in GPCR-targeting Drug Business (2018-2023)
11.11.5 Cisbio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global GPCR-targeting Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Reagent Test Kit
Table 3. Key Players of Substrate
Table 4. Global GPCR-targeting Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global GPCR-targeting Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global GPCR-targeting Drug Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global GPCR-targeting Drug Market Share by Region (2018-2023)
Table 8. Global GPCR-targeting Drug Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global GPCR-targeting Drug Market Share by Region (2024-2033)
Table 10. GPCR-targeting Drug Market Trends
Table 11. GPCR-targeting Drug Market Drivers
Table 12. GPCR-targeting Drug Market Challenges
Table 13. GPCR-targeting Drug Market Restraints
Table 14. Global GPCR-targeting Drug Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global GPCR-targeting Drug Market Share by Players (2018-2023)
Table 16. Global Top GPCR-targeting Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GPCR-targeting Drug as of 2022)
Table 17. Ranking of Global Top GPCR-targeting Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by GPCR-targeting Drug Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players GPCR-targeting Drug Product Solution and Service
Table 21. Date of Enter into GPCR-targeting Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global GPCR-targeting Drug Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global GPCR-targeting Drug Revenue Market Share by Type (2018-2023)
Table 25. Global GPCR-targeting Drug Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global GPCR-targeting Drug Revenue Market Share by Type (2024-2033)
Table 27. Global GPCR-targeting Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global GPCR-targeting Drug Revenue Market Share by Application (2018-2023)
Table 29. Global GPCR-targeting Drug Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global GPCR-targeting Drug Revenue Market Share by Application (2024-2033)
Table 31. North America GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America GPCR-targeting Drug Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America GPCR-targeting Drug Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe GPCR-targeting Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe GPCR-targeting Drug Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific GPCR-targeting Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific GPCR-targeting Drug Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific GPCR-targeting Drug Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America GPCR-targeting Drug Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America GPCR-targeting Drug Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa GPCR-targeting Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa GPCR-targeting Drug Market Size by Country (2024-2033) & (US$ Million)
Table 46. PerkinElmer Company Detail
Table 47. PerkinElmer Business Overview
Table 48. PerkinElmer GPCR-targeting Drug Product
Table 49. PerkinElmer Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)
Table 50. PerkinElmer Recent Development
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific GPCR-targeting Drug Product
Table 54. Thermo Fisher Scientific Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Merck Company Detail
Table 57. Merck Business Overview
Table 58. Merck GPCR-targeting Drug Product
Table 59. Merck Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)
Table 60. Merck Recent Development
Table 61. BD Biosciences Company Detail
Table 62. BD Biosciences Business Overview
Table 63. BD Biosciences GPCR-targeting Drug Product
Table 64. BD Biosciences Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)
Table 65. BD Biosciences Recent Development
Table 66. Molecular Devices Company Detail
Table 67. Molecular Devices Business Overview
Table 68. Molecular Devices GPCR-targeting Drug Product
Table 69. Molecular Devices Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)
Table 70. Molecular Devices Recent Development
Table 71. Promega Company Detail
Table 72. Promega Business Overview
Table 73. Promega GPCR-targeting Drug Product
Table 74. Promega Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)
Table 75. Promega Recent Development
Table 76. Qiagen Company Detail
Table 77. Qiagen Business Overview
Table 78. Qiagen GPCR-targeting Drug Product
Table 79. Qiagen Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)
Table 80. Qiagen Recent Development
Table 81. Abcam Company Detail
Table 82. Abcam Business Overview
Table 83. Abcam GPCR-targeting Drug Product
Table 84. Abcam Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)
Table 85. Abcam Recent Development
Table 86. Corning Company Detail
Table 87. Corning Business Overview
Table 88. Corning GPCR-targeting Drug Product
Table 89. Corning Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)
Table 90. Corning Recent Development
Table 91. Discoverx Company Detail
Table 92. Discoverx Business Overview
Table 93. Discoverx GPCR-targeting Drug Product
Table 94. Discoverx Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)
Table 95. Discoverx Recent Development
Table 96. Cisbio Company Detail
Table 97. Cisbio Business Overview
Table 98. Cisbio GPCR-targeting Drug Product
Table 99. Cisbio Revenue in GPCR-targeting Drug Business (2018-2023) & (US$ Million)
Table 100. Cisbio Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global GPCR-targeting Drug Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global GPCR-targeting Drug Market Share by Type: 2022 VS 2033
Figure 3. Reagent Test Kit Features
Figure 4. Substrate Features
Figure 5. Global GPCR-targeting Drug Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global GPCR-targeting Drug Market Share by Application: 2022 VS 2033
Figure 7. Oncology Case Studies
Figure 8. Cardiovascular Case Studies
Figure 9. Central Nervous Case Studies
Figure 10. Other Case Studies
Figure 11. GPCR-targeting Drug Report Years Considered
Figure 12. Global GPCR-targeting Drug Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global GPCR-targeting Drug Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global GPCR-targeting Drug Market Share by Region: 2022 VS 2033
Figure 15. Global GPCR-targeting Drug Market Share by Players in 2022
Figure 16. Global Top GPCR-targeting Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GPCR-targeting Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by GPCR-targeting Drug Revenue in 2022
Figure 18. North America GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America GPCR-targeting Drug Market Share by Country (2018-2033)
Figure 20. United States GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe GPCR-targeting Drug Market Share by Country (2018-2033)
Figure 24. Germany GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific GPCR-targeting Drug Market Share by Region (2018-2033)
Figure 32. China GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America GPCR-targeting Drug Market Share by Country (2018-2033)
Figure 40. Mexico GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa GPCR-targeting Drug Market Share by Country (2018-2033)
Figure 44. Turkey GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia GPCR-targeting Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. PerkinElmer Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)
Figure 48. Merck Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)
Figure 49. BD Biosciences Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)
Figure 50. Molecular Devices Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)
Figure 51. Promega Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)
Figure 52. Qiagen Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)
Figure 53. Abcam Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)
Figure 54. Corning Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)
Figure 55. Discoverx Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)
Figure 56. Cisbio Revenue Growth Rate in GPCR-targeting Drug Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed